AVITI24™ Lands at Garvan: A Southern Hemisphere First in Multiomic Sequencing
TrendBio is thrilled to announce the installation of the first AVITI24™ system in the Southern Hemisphere at the Garvan Institute of Medical Research, Sydney.
Developed by Element Biosciences, AVITI24™ represents a significant leap forward in spatial biology and multiomic profiling. By combining the precision of next-generation sequencing with high-resolution in situ detection of RNA, DNA, proteins, and cell morphology from a single sample, AVITI24™ is unlocking new possibilities for researchers to explore biology at unprecedented depths.
This milestone brings an entirely new layer of capability to the Australian research community, offering unprecedented opportunities to investigate cellular systems in greater depth and resolution.
What is AVITI24™?
AVITI24™, an intelligent multiomics system, delivers both spatial, single-cell multiomics and high-quality, affordable sequencing. Powered by ABC sequencing, it enables subcellular co-detection of RNA, protein, and morphology—opening up new avenues for discovery in biomedical research and beyond.
Key features
- Industry-Leading Sequencing Quality: Achieve accuracy standards of >90% Q40 and >70% Q50 using Cloudbreak UltraQ sequencing kits
- Fast targeted sequencing with TrinityTM : Enables the fastest exome workflow on the market today
- Teton Cytoprofiling for multiomics readouts: Simultaneous detection of RNA, DNA, proteins, phospho-proteins & cell morphology—all in a single experiment.
- Subcellular resolution: Gain 200nm resolution with a vast imageable area of up to 20 cm² per dual-sided run, profiling up to 2 million cells per run
To learn more about AVITI24™, or to explore collaborative and service opportunities, contact the TrendBio team or the Garvan Genomics Platform:
TrendBio
Garvan Genomics Platform
